TrakCel, Ori Biotech ink supply chain deal for cell and gene therapy
TrakCel was created in 2012 in order to manage the international autologous and allogeneic cell, gene and immunotherapy supply chain.
Read More
Author: Anna Smith
Revlimid gets NICE nod for lymphoma
The decision brings a new option to the market for around 900 patients.
Read More
Sanofi creates European drug ingredients business
When completed, the planned company will allegedly rank as the world’s second largest API company with approximately €1 billion in expected sales by 2022.
Read More
Gilead to kickstart remdesivir coronavirus trial
The hopeful drug in question is Gilead’s investigational broad-spectrum antiviral treatment that was previously tested in humans with Ebola virus.
Read More
Santen EMEA announces RWD on Taptiqom
Taptiqom was efficient in patients with insufficiently controlled open-angle glaucoma (OAG) and ocular hypertension (OHT).
Read More- Palisade Bio reports phase 1a/b data showing colon‑targeted exposure
- MimiVax and Roswell Park open phase 2 trial of SurVaxM for metastatic neuroendocrine tumours
- Myomaker Bio unveils lab‑grown human muscle platform to transform drug testing
- Survodutide delivers 16.6% weight loss in major phase 3 obesity trial
- Kahimmune Therapeutics signs collaboration agreement with Gustave Roussy
